Leif Stenke
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 86
- Chronic Myeloid Leukemia Treatments 65
- Acute Myeloid Leukemia Research 20
- Genetics 45
- Chronic Lymphocytic Leukemia Research 38
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- Satu Mustjoki (21 shared papers)Peter Reizenstein (14 shared papers)Richard A. Larson (5 shared papers)Martin Höglund (22 shared papers)Johan Richter (28 shared papers)Stephen H. Petersdorf (4 shared papers)Harry P. Erba (4 shared papers)Thomas J. Nevill (4 shared papers)
- Journals
- Blood (28 papers)European Journal Of Haematology (10 papers)British Journal of Haematology (6 papers)Leukemia (6 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- SwedenFinlandUnited States
In The Last Decade
Leif Stenke
113 papers receiving 3.1k citations
Leif Stenke's Hit Papers
Peers
Comparison fields: 5 of 107
- Hematology 2.0k
- Genetics 1.0k
- Rheumatology 497
- Oncology 742
- Immunology 475
Countries citing papers authored by Leif Stenke
This map shows the geographic impact of Leif Stenke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Stenke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Stenke more than expected).
Fields of papers citing papers by Leif Stenke
This network shows the impact of papers produced by Leif Stenke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Stenke. The network helps show where Leif Stenke may publish in the future.
Co-authors
The 25 scholars most cited alongside Leif Stenke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia Hit paper breakdown → | 2013 | 464 |
| 2 | 2011 | 379 | |
| 3 | 2009 | 231 | |
| 4 | 2009 | 129 | |
| 5 | 2010 | 124 | |
| 6 | 2017 | 96 | |
| 7 | 2013 | 83 | |
| 8 | 2000 | 80 | |
| 9 | 2011 | 72 | |
| 10 | 2016 | 70 | |
| 11 | 2015 | 57 | |
| 12 | 2014 | 54 | |
| 13 | 1993 | 52 | |
| 14 | 2016 | 49 | |
| 15 | 1991 | 48 | |
| 16 | 1991 | 48 | |
| 17 | 2014 | 47 | |
| 18 | 2015 | 44 | |
| 19 | Prediction of response to treatment with human recombinant erythropoietin in myelodysplastic syndromes. | 1993 | 41 |
| 20 | 1991 | 39 |
About Leif Stenke
Leif Stenke is a scholar working on Hematology, Genetics, Rheumatology, Immunology and Oncology, having authored 114 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (65 papers), Chronic Lymphocytic Leukemia Research (38 papers), Eosinophilic Disorders and Syndromes (24 papers), Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (11 papers), Immune Cell Function and Interaction (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Mast cells and histamine (6 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (1.0k citations), Rheumatology (497 citations), Oncology (742 citations) and Immunology (475 citations). Leif Stenke has collaborated with scholars based in Sweden, Finland and United States. Frequent co-authors include Satu Mustjoki, Peter Reizenstein, Richard A. Larson, Martin Höglund, Johan Richter, Stephen H. Petersdorf, Harry P. Erba, Thomas J. Nevill, Martin S. Tallman and Marilyn L. Slovak. Their work appears in journals such as Blood, European Journal Of Haematology, British Journal of Haematology, Leukemia and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.